Literature DB >> 19898265

PharmGKB summary: very important pharmacogene information for angiotensin-converting enzyme.

Caroline F Thorn1, Teri E Klein, Russ B Altman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 19898265      PMCID： PMC3098760          DOI： 10.1097/FPC.0b013e3283339bf3

Source DB:  PubMed          Journal:  Pharmacogenet Genomics        ISSN： 1744-6872            Impact factor:   2.089


× No keyword cloud information.
  48 in total

1.  Interactions between angiotensin-I converting enzyme insertion/deletion polymorphism and response of plasma lipids and coronary atherosclerosis to treatment with fluvastatin: the lipoprotein and coronary atherosclerosis study.

Authors:  A J Marian; F Safavi; L Ferlic; J K Dunn; A M Gotto; C M Ballantyne
Journal:  J Am Coll Cardiol       Date:  2000-01       Impact factor: 24.094

2.  Predicting response to chronic antihypertensive treatment with fosinopril: the role of angiotensin-converting enzyme gene polymorphism.

Authors:  G A Stavroulakis; T K Makris; P G Krespi; A N Hatzizacharias; A E Gialeraki; G Anastasiadis; P Triposkiadis; M Kyriakidis
Journal:  Cardiovasc Drugs Ther       Date:  2000-08       Impact factor: 3.727

3.  Associations of baseline blood pressure levels and efficacy of Benazepril treatment with interaction of alpha-adducin and ACE gene polymorphisms in hypertensives.

Authors:  Yunxian Yu; Tianhua Niu; Scott Alan Venners; Yan Zhang; Changzhong Chen; Aiqun Huang; Yan Feng; Dong Li; Houxun Xing; Di Wu; Shaojie Peng; Xiping Xu
Journal:  Clin Exp Hypertens       Date:  2005-01       Impact factor: 1.749

4.  Angiotensin converting enzyme gene polymorphism predicts blood pressure response to angiotensin II receptor type 1 antagonist treatment in hypertensive patients.

Authors:  L Kurland; H Melhus; J Karlsson; T Kahan; K Malmqvist; K P Ohman; F Nyström; A Hägg; L Lind
Journal:  J Hypertens       Date:  2001-10       Impact factor: 4.844

5.  Increased risk for ischaemic events is related to combined RAS polymorphism.

Authors:  P P van Geel; Y M Pinto; A H Zwinderman; R H Henning; A J van Boven; J W Jukema; A V Bruschke; J J Kastelein; W H van Gilst
Journal:  Heart       Date:  2001-04       Impact factor: 5.994

6.  The N-terminal active centre of human angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide.

Authors:  Ryutaro Oba; Akira Igarashi; Makiko Kamata; Kinya Nagata; Syoichi Takano; Hachiro Nakagawa
Journal:  Eur J Neurosci       Date:  2005-02       Impact factor: 3.386

7.  ACE DD genotype is more susceptible than ACE II and ID genotypes to the antiproteinuric effect of ACE inhibitors in patients with proteinuric non-insulin-dependent diabetes mellitus.

Authors:  S K Ha; S Yong Lee; H Su Park; J Ho Shin; S Jung Kim; D Hun Kim; K Rae Kim; H Yung Lee; D Suk Han
Journal:  Nephrol Dial Transplant       Date:  2000-10       Impact factor: 5.992

Review 8.  The angiotensin-converting enzyme gene family: genomics and pharmacology.

Authors:  Anthony J Turner; Nigel M Hooper
Journal:  Trends Pharmacol Sci       Date:  2002-04       Impact factor: 14.819

9.  Sequence variation in the human angiotensin converting enzyme.

Authors:  M J Rieder; S L Taylor; A G Clark; D A Nickerson
Journal:  Nat Genet       Date:  1999-05       Impact factor: 38.330

10.  Maternal use of antihypertensive drugs in early pregnancy and delivery outcome, notably the presence of congenital heart defects in the infants.

Authors:  Roland Lennestål; Petra Otterblad Olausson; Bengt Källén
Journal:  Eur J Clin Pharmacol       Date:  2009-02-07       Impact factor: 2.953
View more
  5 in total

1.  Pharmacogenomics and bioinformatics: PharmGKB.

Authors:  Caroline F Thorn; Teri E Klein; Russ B Altman
Journal:  Pharmacogenomics       Date:  2010-04       Impact factor: 2.533

2.  Worldwide spatial genetic structure of angiotensin-converting enzyme gene: a new evolutionary ecological evidence for the thrifty genotype hypothesis.

Authors:  Xiao Li; Xiubin Sun; Li Jin; Fuzhong Xue
Journal:  Eur J Hum Genet       Date:  2011-05-11       Impact factor: 4.246

3.  Are "functionally related polymorphisms" of renin-angiotensin-aldosterone system gene polymorphisms associated with hypertension?

Authors:  Ines N Hahntow; Gideon Mairuhu; Irene Gm van Valkengoed; Richard P Koopmans; Martin C Michel
Journal:  BMC Cardiovasc Disord       Date:  2010-06-02       Impact factor: 2.298

Review 4.  Pharmacogenomics of breast cancer therapy: an update.

Authors:  Kelly Westbrook; Vered Stearns
Journal:  Pharmacol Ther       Date:  2013-03-13       Impact factor: 12.310

5.  Analysis of population-specific pharmacogenomic variants using next-generation sequencing data.

Authors:  Eunyong Ahn; Taesung Park
Journal:  Sci Rep       Date:  2017-09-04       Impact factor: 4.379
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.